Research ArticleCancer

Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

See allHide authors and affiliations

Science Translational Medicine  01 Apr 2020:
Vol. 12, Issue 537, eaaz3577
DOI: 10.1126/scitranslmed.aaz3577

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article